Department of Physiology and Pharmacology, Faculty of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, AB, Canada T2N 4N1.
Cardiovasc Res. 2013 Feb 1;97(2):339-48. doi: 10.1093/cvr/cvs326. Epub 2012 Oct 31.
Endothelial SK(Ca) and IK(Ca) channels play an important role in the regulation of vascular function and systemic blood pressure. Based on our previous findings that small molecule activators of SK(Ca) and IK(Ca) channels (i.e. NS309 and SKA-31) can inhibit myogenic tone in isolated resistance arteries, we hypothesized that this class of compounds may induce effective vasodilation in an intact vascular bed, such as the coronary circulation.
In a Langendorff-perfused, beating rat heart preparation, acute bolus administrations of SKA-31 (0.01-5 µg) dose-dependently increased total coronary flow (25-30%) in both male and female hearts; these responses were associated with modest, secondary increases in left ventricular (LV) systolic pressure and heart rate. SKA-31 evoked responses in coronary flow, LV pressure, and heart rate were qualitatively comparable to acute responses evoked by bradykinin (1 µg) and adenosine (10 µg). In the presence of apamin and TRAM-34, selective blockers of SK(Ca) and IK(Ca) channels, respectively, SKA-31 and bradykinin-induced responses were largely inhibited, whereas the adenosine-induced changes were blocked by ∼40%; TRAM-34 alone produced less inhibition. Sodium nitroprusside (SNP, 0.2 μg bolus dose) evoked changes in coronary flow, LV pressure, and heart rate were similar to those induced by SKA-31, but were unaffected by apamin + TRAM-34. The NOS inhibitor L-NNA reduced bradykinin- and adenosine-evoked changes, but did not affect responses to either SKA-31 or SNP.
Our study demonstrates that SKA-31 can rapidly and reversibly induce dilation of the coronary circulation in intact functioning hearts under basal flow and contractility conditions.
内皮 SK(Ca) 和 IK(Ca) 通道在调节血管功能和全身血压方面发挥着重要作用。基于我们之前的发现,即 SK(Ca) 和 IK(Ca) 通道的小分子激活剂(即 NS309 和 SKA-31)可以抑制分离的阻力血管中的肌源性张力,我们假设此类化合物可能在完整的血管床(如冠状循环)中引起有效的血管舒张。
在 Langendorff 灌注跳动的大鼠心脏制剂中,SKA-31(0.01-5μg)的急性单次给药剂量依赖性地增加了雄性和雌性心脏的总冠脉流量(25-30%);这些反应与左心室(LV)收缩压和心率的适度继发性增加相关。SKA-31 引起的冠脉流量、LV 压力和心率反应与急性缓激肽(1μg)和腺苷(10μg)引起的反应在性质上相似。在分别选择性阻断 SK(Ca) 和 IK(Ca) 通道的 apamin 和 TRAM-34 的存在下,SKA-31 和缓激肽诱导的反应被大大抑制,而腺苷诱导的变化被抑制约 40%;TRAM-34 本身的抑制作用较小。硝普钠(SNP,0.2μg 单次剂量)引起的冠脉流量、LV 压力和心率变化与 SKA-31 诱导的变化相似,但不受 apamin+TRAM-34 的影响。NOS 抑制剂 L-NNA 减少了缓激肽和腺苷引起的变化,但对 SKA-31 或 SNP 的反应没有影响。
我们的研究表明,SKA-31 可以在基础流量和收缩性条件下迅速和可逆地诱导完整功能心脏的冠脉循环扩张。